Global 3D Cell Culture Market (2018-2025)-GMI Research Global 3D Cell Culture Market (2018-2025)-GMI Rese | Page 2

drug discovery and toxicology testing as well as cancer research as traditional
2D cell culture may not accurately mimic the 3D environment in which cancer
cells reside. These start-to-end cell culture solutions can save money and time
along with improving end results.
Download Sample Brochure : https://www.gmiresearch.com/sample-research-
report.php?rid=126
The 3D cell culture market growth is mainly driven by increased oncology drug
discovery studies, rising investments in the field, favourable government policies
and support, and the use of 3D cell cultures as an alternative to animal testing in
toxicology studies. The technology has major application in the area of cancer
drug development as use of 3D cell culture enhances physiological relevance of
cell-based assays giving meaningful results.
Various researches are also focusing on using advanced 3D cell culture models
to test efficiency and effect of the new cancer drug. For instance, in March 2018,
Institute for Research in Biomedicine (IRB), Barcelona developed a mouse model
to study immune system response in advanced human colon cancer using
AMSBIO’s 3D organoid culture technology. Such developments are set to further
boost the demand for 3D cell culture technology.
Various prominent players operating in the 3D cell culture market include 3D
Biotek, AMSBIO, Corning Lifesciences, Synthecon, MilliporeSigma, Thermo
Fisher Scientific, and Nanofiber Solutions among others.
The global 3D cell culture market has been categorized based on technology,
application, and key geographies. Technology segmentation of market includes
Scaffold-free, Scaffold-based, and others. Scaffold-free segment is further sub-
segmented into Low Attachment Surfaces, Hanging Drop Method, 3D Petri
Dishes, and 3D Bioreactors. While Scaffold-based market is sub-segmented into